AIベースの臨床試験ソリューション提供企業市場レポート：2023-2033
AI-based Clinical Trial Solution Providers Market Report 2023-2033
レポート詳細
A Iベースの臨床試験ソリューション提供企業市場レポート 2023-2033年 ： 本レポートは、業界とその基礎となる原動力をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にと... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
AIベースの臨床試験ソリューション提供企業市場レポート 2023-2033年： 本レポートは、業界とその基礎となる原動力をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新規地域での既存事業の拡大を目指す企業にも有用です。
臨床試験数の増加と研究開発投資が業界の成長を後押し
様々な治療領域で実施される臨床試験数が大幅に増加している。この急増は、革新的な治療法の必要性、疾病の蔓延、医療技術の進歩など、いくつかの要因に起因している。臨床試験数の増加は、効率的かつ効果的なソリューションに対する需要を生み出し、AIベースの臨床試験ソリューションの採用につながる。製薬業界とバイオテクノロジー業界は、新薬、治療法、治療アプローチを開発するための研究開発活動に多額の投資を行っている。こうした投資の背景には、アンメット・メディカル・ニーズに対応し、患者の転帰を改善し、市場での競争力を獲得する必要性がある。AIベースのソリューションは、研究開発プロセスを最適化し、創薬を加速し、臨床試験の効率を向上させる計り知れない可能性を提供するため、この分野への投資が増加している。
臨床試験におけるAIベースのソリューション採用へのシフトが顕著である。データ分析の強化、患者の募集と維持の改善、臨床試験管理の合理化など、AIが提供する利点が業界で認知されるようになった。その結果、製薬企業、医薬品開発業務受託機関（CRO）、学術機関は、AIベースのソリューションを臨床試験プロセスに統合し、そのメリットを活用する動きが加速している。
これらの要因が総合的にAIベースの臨床試験ソリューション市場の成長に寄与しており、臨床試験の状況における進化するニーズや課題に対応できる高度な技術やソリューションに対する需要を後押ししている。
データプライバシーとセキュリティの問題が業界の成長を阻むと予測される
AIベースの臨床試験ソリューション提供企業の市場にとって、セキュリティとデータ漏洩は大きな課題となる。臨床試験において、患者の機密データを保護することは最も重要である。しかし、臨床試験においてテクノロジーの利用やデータ生成が急増するにつれ、データ漏洩やサイバー攻撃の可能性も高まっている。
AIベースのソリューションは機械学習アルゴリズムに大きく依存しており、その学習と精度向上のためには膨大なデータが必要となる。残念なことに、このデータはセキュリティ侵害やサイバー攻撃の影響を受けやすく、患者の守秘義務を危うくする。このような侵害は、臨床試験データの取り扱いに携わる企業にとって、深刻な法的影響や風評被害をもたらす可能性がある。
市場調査レポートを購入する前にすべき質問とは？
- AIベースの臨床試験ソリューション提供企業市場はどのように進化しているのか？
- AIベースの臨床試験ソリューション提供企業市場の推進要因と抑制要因は何か？
- AIベースの臨床試験ソリューション提供企業の各サブマーケットセグメントは予測期間中にどのように成長し、これらのサブマーケットが2033年にどれくらいの収益を占めるのか？
- AIベースの臨床試験ソリューション提供企業の各サブマーケットの市場シェアは2023年から2033年にかけてどのように推移するのか？
- 2023年から2033年にかけて市場全体の主な牽引役となるのは何か？
- AIベースの臨床試験ソリューション提供企業の主要市場はマクロ経済の動きに大枠で追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年の市場をリードするのか？
- 主要プレーヤーは誰で、予測期間中の見通しは？
- 2020年から2033年にかけて、業界はどのように進化するのか？AIベースの臨床試験ソリューション提供企業のプロジェクトは、現在および今後10年間でどのような意味を持つのか？
- AIベースの臨床試験ソリューション提供企業市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
- AIベースの臨床試験ソリューション提供企業市場はどこに向かっており、どのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新しいGrに移行させるための主な展望とは？
AIベースの臨床試験ソリューション提供企業市場に現在、そして今後10年間でどのような影響を与えるかを見極める必要がある：
- 274ページにわたる本レポートでは、104の表、147の図表を掲載しています。
- 本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、AIベースの臨床試験ソリューション提供企業市場が今後10年間でどのように発展し、COVID-19の景気後退と好転の変動に合わせて変化するかをお伝えします。この市場は過去10年間のどの時点よりも今が重要である。
2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、AIベースの臨床試験ソリューションプロバイダーの価格上昇の影響、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
提供形態
- クラウドベース
- オンプレミス
- ハイブリッドソリューション
臨床試験フェーズ
- フェーズ1
- フェーズ2
- フェーズ3
治療領域
- 腫瘍学的疾患
- 中枢神経系疾患
- 感染症
- 心血管疾患
- 代謝疾患
- その他
エンドユーザー
- 製薬会社
- アカデミア
- その他
世界市場全体とセグメント別の収益予測に加え、4つの地域と20の主要国市場の収益予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- スペイン
- 英国
- フランス
- イタリア
- その他の欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ
MEA
- GCC諸国
- 南アフリカ
- その他のMEA
本レポートでは、AIベースの臨床試験ソリューション提供企業市場の2023年から2033年にかけての主要企業のプロファイルも掲載しており、これらの企業の事業のこのセグメントに焦点を当てている。
主要企業と市場成長の可能性
・ AiCure
・ BioAge Labs, Inc.
・ Deep6.ai
・ Exscientia
・ Innoplexus
・ Intelligencia.ai
・ Median Technologies
・ Medidata (Dassault Systemes)
・ Merative
・ Saama Technologies, LLC
AIベースの臨床試験ソリューション提供企業市場全体の世界売上高、2023年から2033年までの金額ベースでは、2023年に14億7,500万米ドルを突破するとの試算を発表した。2033年まで収益は力強く成長すると予測している。当研究所では、最も大きな可能性を秘めた組織を特定する。各社の能力、進捗状況、商業的展望をご覧いただき、一歩先を行くための一助としてください。
AIベースの臨床試験ソリューション提供企業市場、2023〜2033年レポートが貴社のお役に立つでしょうか？
要約すると、270ページを超えるこのレポートは、以下のような知識を提供する：
- AIベースの臨床試験ソリューション提供企業市場の2023年から2033年までの収益予測 世界および地域レベルで、提供形態、臨床試験フェーズ、治療分野、エンドユーザーごとに予測 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけます。
- 4つの地域と20の主要国市場の2033年までの収益予測 - AIベースの臨床試験ソリューション提供企業市場、北米、欧州、アジア太平洋、中南米、MEAの2023年から2033年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
- AIベースの臨床試験ソリューション提供企業市場に関わる主要企業10社の企業プロファイルを含む、2023年から2033年までの既存企業および市場参入を目指す企業の展望。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社の調査結果が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、AIベースの臨床試験ソリューション提供企業市場、2023年から2033年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 AIベースの臨床試験ソリューション提供企業市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブサマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 臨床試験数の増加と研究開発投資の増加
3.2.1.2 臨床試験におけるAIベースのソリューション採用の増加
3.2.1.3 AIベースのソリューションの技術的進歩
3.2.2 市場抑制要因
3.2.2.1 熟練した専門家の不足
3.2.2.2 データプライバシーとセキュリティの問題
3.2.2.3 規制と倫理的課題
3.2.3 市場機会
3.2.3.1 AIベースの臨床試験ソリューション提供企業間のアウトソーシングと戦略的関係
3.2.3.2 慢性疾患の有病率の増加
3.2.3.3 より正確で個別化された治療に対する需要の増加
3.3 COVID-19インパクト分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 AIベースの臨床試験ソリューション提供企業市場分析：提供形態別
4.1 主な調査結果
4.2 配信形態セグメント 市場魅力度指数
4.3 AIベースの臨床試験ソリューション提供企業の提供形態別市場規模推定と予測
4.4 クラウドベース
4.4.1 2023年～2033年の地域別市場規模（US$ Million）
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 オンプレミス型
4.5.1 2023年～2033年の地域別市場規模（US$ Million）
4.5.2 地域別市場シェア、2023年・2033年 (%)
4.6 ハイブリッドソリューション
4.6.1 2023年～2033年の地域別市場規模（US$ Million）
4.6.2 地域別市場シェア、2023年・2033年 (%)
5 AIベースの臨床試験ソリューション提供企業市場分析：臨床試験フェーズ別
5.1 主な調査結果
5.2 臨床試験フェーズ別セグメント 市場魅力度指数
5.3 AIベースの臨床試験ソリューション提供企業の臨床試験フェーズ別市場規模推定と予測
5.4 フェーズ1
5.4.1 2023年～2033年の地域別市場規模（US$ Million）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 フェーズ2
5.5.1 2023年～2033年の地域別市場規模（US$ Million）
5.5.2 地域別市場シェア、2023年・2033年 (%)
5.6 フェーズ3
5.6.1 2023年～2033年の地域別市場規模（US$ Million）
5.6.2 地域別市場シェア、2023年・2033年 (%)
6 AIベースの臨床試験ソリューション提供企業市場分析：治療分野別
6.1 主な調査結果
6.2 治療領域セグメント市場魅力度指数
6.3 AIベースの臨床試験ソリューション提供企業の治療領域別市場規模推定と予測
6.4 腫瘍性疾患
6.4.1 2023年～2033年の地域別市場規模（US$ Million）
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 中枢神経系疾患
6.5.1 2023年～2033年の地域別市場規模（US$ Million）
6.5.2 地域別市場シェア、2023年・2033年 (%)
6.6 感染症
6.6.1 2023年～2033年の地域別市場規模（US$ Million）
6.6.2 地域別市場シェア、2023年・2033年(%)
6.7 循環器疾患
6.7.1 2023年～2033年の地域別市場規模（US$ Million）
6.7.2 地域別市場シェア、2023年・2033年 (%)
6.8 代謝性疾患
6.8.1 2023年～2033年の地域別市場規模（US$ Million）
6.8.2 地域別市場シェア、2023年・2033年 (%)
6.9 その他
6.9.1 2023年～2033年の地域別市場規模（US$ Million）
6.9.2 地域別市場シェア、2023年・2033年 (%)
7 AIベースの臨床試験ソリューション提供企業市場分析：エンドユーザー別
7.1 主要調査結果
7.2 エンドユーザーセグメント：市場魅力度指数
7.3 AIベースの臨床試験ソリューション提供企業のエンドユーザー別市場規模推定と予測
7.4 製薬企業
7.4.1 2023年～2033年の地域別市場規模（US$ Million）
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 アカデミア
7.5.1 2023年～2033年の地域別市場規模（US$ Million）
7.5.2 地域別市場シェア、2023年・2033年 (%)
7.6 その他
7.6.1 2023年～2033年の地域別市場規模（US$ Million）
7.6.2 地域別市場シェア、2023年・2033年 (%)
8 AIベースの臨床試験ソリューション提供企業市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測
9 北米のAIベースの臨床試験ソリューション提供企業市場分析
9.1 主要な調査結果
9.2 北米のAIベースの臨床試験ソリューション提供企業市場魅力度指数
9.3 北米のAIベースの臨床試験ソリューション提供企業国別市場、2023年、2028年、2033年（US$ Million）
9.4 北米のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：国別
9.5 北米のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：提供形態別
9.6 北米のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：臨床試験フェーズ別
9.7 北米のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：治療分野別
9.8 北米のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：エンドユーザー別
9.9 米国AIベースの臨床試験ソリューション提供企業市場分析
9.10 カナダのAIベースの臨床試験ソリューション提供企業市場分析
10 欧州のAIベースの臨床試験ソリューション提供企業市場分析
10.1 主要な調査結果
10.2 AIベースの臨床試験ソリューション提供企業の欧州市場魅力度指数
10.3 欧州のAIベースの臨床試験ソリューション提供企業の国別市場、2023年、2028年、2033年（US$ Million）
10.4 欧州のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：国別
10.5 欧州のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：提供形態別
10.6 欧州のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：臨床試験フェーズ別
10.7 欧州のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：治療分野別
10.8 欧州のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：エンドユーザー別
10.9 ドイツAIベースの臨床試験ソリューション提供企業市場分析
10.10 フランスのAIベースの臨床試験ソリューション提供企業市場分析
10.11 イギリスのAIベースの臨床試験ソリューション提供企業市場分析
10.12 イタリアのAIベースの臨床試験ソリューション提供企業市場分析
10.13 スペインのAIベースの臨床試験ソリューション提供企業の市場分析
10.14 その他の欧州のAIベースの臨床試験ソリューション提供企業の市場分析
11 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場魅力度指数
11.3 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業の国別市場、2023年、2028年、2033年）（US$ Million）
11.4 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：国別
11.5 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：提供形態別
11.6 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：臨床試験フェーズ別
11.7 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：治療分野別
11.8 アジア太平洋地域のAIベースの臨床試験ソリューション提供企業市場規模推定と予測：エンドユーザー別
11.9 中国のAIベースの臨床試験ソリューション提供企業市場分析
11.10 日本のAIベースの臨床試験ソリューション提供企業市場分析
11.11 インドのAIベースの臨床試験ソリューション提供企業市場分析
11.12 オーストラリアのAIベースの臨床試験ソリューション提供企業の市場分析
11.13 韓国のAIベースの臨床試験ソリューション提供企業の市場分析
11.14 その他のアジア太平洋地域のAIベースの臨床試験ソリューション提供企業の市場分析
12 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場分析
12.1 主要な調査結果
12.2 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場魅力度指数
12.3 ラテンアメリカのAIベースの臨床試験ソリューション提供企業国別市場、2023年、2028年、2033年 (US$ Million)
12.4 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：国別
12.5 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：提供形態別
12.6 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：臨床試験フェーズ別
12.7 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：治療分野別
12.8 ラテンアメリカのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：エンドユーザー別
12.9 ブラジルのAIベースの臨床試験ソリューション提供企業市場分析
12.10 メキシコAIベースの臨床試験ソリューション提供企業市場分析
12.11 その他のラテンアメリカのAIベースの臨床試験ソリューション提供企業市場分析
13 MEAのAIベースの臨床試験ソリューション提供企業市場分析
13.1 主要な調査結果
13.2 MEAのAIベースの臨床試験ソリューション提供企業市場魅力度指数
13.3 MEAのAIベースの臨床試験ソリューション提供企業の国別市場、2023年、2028年、2033年(US$ Million)
13.4 MEAのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：国別
13.5 MEAのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：提供形態別
13.6 MEAのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：臨床試験フェーズ別
13.7 MEAのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：治療分野別
13.8 MEAのAIベースの臨床試験ソリューション提供企業市場規模推定と予測：エンドユーザー別
13.9 GCCのAIベースの臨床試験ソリューション提供企業市場分析
13.10 南アフリカのAIベースの臨床試験ソリューション提供企業市場分析
13.11 その他のMEAのAIベースの臨床試験ソリューション提供企業の市場分析
14 主要企業のプロフィール
14.1 競争環境、2022年
14.2 戦略的展望
14.3 Medidata (Dassault Systemes)
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 売上高、2018年～2022年
14.3.3.2 地域市場シェア、2022年
14.3.3.3 研究開発費、2018年～2022年
14.3.4 製品ベンチマーク
14.3.5 戦略的展望
14.4 Merative
14.4.1 会社概要
14.4.2 会社概要
14.4.3 製品ベンチマーク
14.4.4 戦略的展望
14.5 Saama Technologies, LLC
14.5.1 会社概要
14.5.2 会社概要
14.5.3 製品ベンチマーク
14.5.4 戦略的展望
14.6 Exscientia
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 売上高、2021-2022年
14.6.3.2 地域市場シェア、2022年
14.6.3.3 研究開発費、2021-2022年
14.6.4 製品ベンチマーク
14.6.5 戦略的展望
14.7 Innoplexus
14.7.1 会社概要
14.7.2 会社概要
14.7.3 製品ベンチマーク
14.7.4 戦略的展望
14.8 Median Technologies
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 売上高、2018年～2022年
14.8.3.2 地域市場シェア、2022年
14.8.4 製品ベンチマーク
14.8.5 戦略的展望
14.9 Deep6.ai
14.9.1 会社概要
14.9.2 会社概要
14.9.3 製品ベンチマーク
14.9.4 戦略的展望
14.10 AiCure
14.10.1 会社概要
14.10.2 会社概要
14.10.3 製品ベンチマーク
14.10.4 戦略的展望
14.11 BioAge Labs, Inc.
14.11.1 会社概要
14.11.2 会社概要
14.11.3 製品ベンチマーク
14.11.4 戦略的展望
14.12 Intelligencia.ai
14.12.1 会社概要
14.12.2 会社概要
14.12.3 製品ベンチマーク
15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 AI-based Clinical Trial Solution Providers Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Total Clinical Trials by Phase of Development
Table 3 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 4 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 5 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 7 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cloud-based Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 On-premises Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Hybrid Solutions Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Phase 3 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Phase 2 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Phase 1 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Oncological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 CNS Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Infectious Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million,
Table 19 AGR%, CAGR%)
Table 20 Cardiovascular Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Metabolic Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million,
Table 22 AGR%, CAGR%)
Table 23 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Academia Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 U.S. AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Canada AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 36 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country,
Table 37 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 France AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 U.K. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Italy AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Spain AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Rest of Europe AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 China AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Japan AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 India AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Australia AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 South Korea AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Brazil AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Mexico AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 Medidata (Dassault Systemes): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Medidata (Dassault Systemes): Service Benchmarking
Table 78 Medidata (Dassault Systemes): Strategic Outlook
Table 79 Merative: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Merative: Service Benchmarking
Table 81 Merative: Strategic Outlook
Table 82 Saama Technologies, LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Saama Technologies, LLC: Service Benchmarking
Table 84 Saama Technologies, LLC: Strategic Outlook
Table 85 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Exscientia: Service Benchmarking
Table 87 Innoplexus: Strategic Outlook
Table 88 Innoplexus: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Innoplexus.: Service Benchmarking
Table 90 Innoplexus: Strategic Outlook
Table 91 Median Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Median Technologies: Done Benchmarking
Table 93 Innoplexus: Strategic Outlook
Table 94 Deep6.ai: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Deep6.ai: Service Benchmarking
Table 96 Deep6.ai: Strategic Outlook
Table 97 AiCure: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 AiCure: Service Benchmarking
Table 99 AiCure: Strategic Outlook
Table 100 BioAge Labs, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 BioAge Labs, Inc.: Service Benchmarking
Table 102 BioAge Labs, Inc.: Strategic Outlook
Table 103 Intelligencia.ai: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Intelligencia.ai: Service Benchmarking
図の一覧
Figure 1 AI-based Clinical Trial Solution Providers Market Segmentation
Figure 2 AI-based Clinical Trial Solution Providers Market by Mode of Delivery: Market Attractiveness Index
Figure 3 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase: Market Attractiveness Index
Figure 4 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 5 AI-based Clinical Trial Solution Providers Market Forecast by End-users: Market Attractiveness Index
Figure 6 AI-based Clinical Trial Solution Providers Market Attractiveness Index by Region
Figure 7 AI-based Clinical Trial Solution Providers Market: Market Dynamics
Figure 8 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 AI-based Clinical Trial Solution Providers Market: Porter’s Five Forces Analysis
Figure 13 AI-based Clinical Trial Solution Providers Market: PEST Analysis
Figure 14 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery: Market Attractiveness Index
Figure 15 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 16 AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023, 2028, 2033 (%)
Figure 17 Cloud-based Market Forecast by Region, 2023 2033 (US$ Million)
Figure 18 Cloud-based Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 On-premises Market Forecast by Region, 2023-2033 (US$ Million)
Figure 20 On-premises Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Hybrid Solutions Market Forecast by Region, 2023-2033 (US$ Million)
Figure 22 Hybrid Solutions Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase: Market Attractiveness Index
Figure 24 AI-based Clinical Trial Solution Providers Market Forecast By Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 25 AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023, 2028, 2033 (%)
Figure 26 Phase 3 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Phase 3 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase 2 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Phase 2 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase 1 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 33 AI-based Clinical Trial Solution Providers Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
Figure 34 AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 35 Oncological Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 36 Oncological Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 CNS Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 38 CNS Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Infectious Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 40 Infectious Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Cardiovascular Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 42 Cardiovascular Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Metabolic Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 44 Metabolic Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 46 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 AI-based Clinical Trial Solution Providers Market Forecast by End-users: Market Attractiveness Index
Figure 48 AI-based Clinical Trial Solution Providers Market Forecast By End-users, 2023-2033 (US$ Million)
Figure 49 AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 50 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 51 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Academia Market Forecast by Region, 2023-2033 (US$ Million)
Figure 53 Academia Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 55 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 57 AI-based Clinical Trial Solution Providers Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 58 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 59 North America AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 60 North America AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 61 North America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 62 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 64 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 65 North America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ million)
Figure 66 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 67 North America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 68 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 69 North America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 70 North America AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 71 U.S. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Canada AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 74 Europe AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 75 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 76 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 78 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 79 Europe AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 80 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 81 Europe AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 82 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 83 Europe AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 84 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Germany AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 France AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 U.K. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Italy AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Spain AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Rest of Europe AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Asia Pacific AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 92 Asia Pacific AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 93 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 94 Asia Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 96 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 97 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 98 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 99 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 100 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 101 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 102 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 103 China AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Japan AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 105 India AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Australia AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 South Korea AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Latin America AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 110 Latin America AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 112 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 114 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 115 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 116 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 117 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 118 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 119 Latin America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 120 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 121 Brazil AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 Mexico AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 123 Rest of Latin America AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 MEA AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 125 MEA AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 126 MEA AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 127 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 128 MEA AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 129 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 130 MEA AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 131 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 132 MEA AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 133 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 134 MEA AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 135 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 136 GCC AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 137 South Africa AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 138 Rest of MEA AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 AI-based Clinical Trial Solution Providers Market: Company Share Analysis, 2022
Figure 140 Medidata (Dassault Systemes): Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 141 Medidata (Dassault Systemes): Regional Market Shares, 2022
Figure 142 Dassault Systèmes: R&D Expense, 2018-2022 (US$ million, AGR%)
Figure 143 Exscientia: Revenue, 2021-2022 (US$ Million, AGR%)
Figure 144 Exscientia: Regional Market Shares, 2022
Figure 145 Exscientia: R&D Expense, 2021-2022 (US$ million, AGR%)
Figure 146 Median Technologies: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 147 Median Technologies: Regional Market Shares, 2022
ページTOPに戻る
Summary
Report Details
The AI-based Clinical Trial Solution Providers Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Number of Clinical Trials Coupled with R&D Investments to Boost Industry Growth
There has been a significant increase in the number of clinical trials being conducted across various therapeutic areas. This surge can be attributed to several factors, including the need for innovative treatments, the growing prevalence of diseases, and advancements in medical technology. The higher number of clinical trials creates a demand for efficient and effective solutions, leading to the adoption of AI-based clinical trial solutions. The pharmaceutical and biotechnology industries are investing heavily in R&D activities to develop new drugs, therapies, and treatment approaches. These investments are driven by the need to address unmet medical needs, improve patient outcomes, and gain a competitive edge in the market. AI-based solutions offer immense potential to optimize the R&D process, accelerate drug discovery, and improve clinical trial efficiency, thereby attracting increased investments in this field.
There is a notable shift towards the adoption of AI-based solutions in clinical trials. The advantages offered by AI, such as enhanced data analysis, improved patient recruitment and retention, and streamlined trial management, have gained recognition in the industry. As a result, pharmaceutical companies, contract research organizations (CROs), and academic institutions are increasingly integrating AI-based solutions into their clinical trial processes to leverage the benefits they provide.
These factors collectively contribute to the growth of the market for AI-based clinical trial solutions, as they drive the demand for advanced technologies and solutions that can address the evolving needs and challenges in the clinical trial landscape.
Data Privacy and Security Issues Anticipated to Challenge Industry Growth
Security and data breaches pose significant challenges for the market of AI-based clinical trial solution providers. Safeguarding sensitive patient data is of utmost importance in clinical trials. However, as technology usage and data generation surge in clinical trials, the potential for data breaches and cyber-attacks also escalates.
AI-based solutions heavily rely on machine learning algorithms that necessitate substantial data for training and enhancing accuracy. Unfortunately, this data becomes susceptible to security breaches and cyber-attacks, jeopardizing patient confidentiality. Such breaches can have severe legal and reputational repercussions for the companies involved in handling clinical trial data.
What Questions Should You Ask before Buying a Market Research Report?
• How is the AI-based clinical trial solution providers market evolving?
• What is driving and restraining the AI-based clinical trial solution providers market?
• How will each AI-based clinical trial solution providers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each AI-based clinical trial solution providers submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading AI-based clinical trial solution providers markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2033? What are the implications of AI-based clinical trial solution providers projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the AI-based clinical trial solution providers market?
• Where is the AI-based clinical trial solution providers market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the AI-based clinical trial solution providers market today, and over the next 10 years:
• Our 274-page report provides 104 tables, 147 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the AI-based clinical trial solution providers market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-based clinical trial solution providers prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Mode of Delivery
• Cloud-based
• On-premises
• Hybrid Solutions
Clinical Trial Phase
• Phase 1
• Phase 2
• Phase 3
Therapeutic Area
• Oncological Disorders
• CNS Disorders
• Infectious Disorders
• Cardiovascular Disorders
• Metabolic Disorders
• Others
End-users
• Pharmaceutical Companies
• Academia
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• Spain
• UK
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC Countries
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the AI-based clinical trial solution providers Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AiCure
• BioAge Labs, Inc.
• Deep6.ai
• Exscientia
• Innoplexus
• Intelligencia.ai
• Median Technologies
• Medidata (Dassault Systemes)
• Merative
• Saama Technologies, LLC
Overall world revenue for AI-based clinical trial solution providers market, 2023 to 2033 in terms of value the market will surpass US$1,475.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the AI-based clinical trial solution providers market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for AI-based clinical trial solution providers market, 2023 to 2033 Market, with forecasts for mode of delivery, clinical trial phase, therapeutic area, and end-users each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the AI-based clinical trial solution providers Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the AI-based clinical trial solution providers market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the AI-based clinical trial solution providers market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to AI-based Clinical Trial Solution Providers Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
3.2.1.2 Increasing Adoption of AI-based Solutions in Clinical Trials
3.2.1.3 Technological Advancements of AI-based Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Shortage of Skilled Professional
3.2.2.2 Data Privacy and Security Issues
3.2.2.3 Regulatory and Ethical Challenges
3.2.3 Market Opportunities
3.2.3.1 Outsourcing and Strategic Relationships Among AI-based Clinical Trial Solution Providers
3.2.3.2 Growing prevalence of chronic diseases
3.2.3.3 Increasing Demand for More Precise and Personalized Treatments
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 AI-based Clinical Trial Solution Providers Market Analysis by Mode of Delivery
4.1 Key Findings
4.2 Mode of Delivery Segment: Market Attractiveness Index
4.3 AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
4.4 Cloud-based
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 On-premises
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Hybrid Solution
4.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.2 Market Share by Region, 2023 & 2033 (%)
5 AI-based Clinical Trial Solution Providers Market Analysis by Clinical Trial Phase
5.1 Key Findings
5.2 Clinical Trial Phase Segment: Market Attractiveness Index
5.3 AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
5.4 Phase 1
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Phase 2
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase 3
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 AI-based Clinical Trial Solution Providers Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncological Disorders
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 CNS Disorders
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Infectious Disorders
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Cardiovascular Disorders
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Metabolic Disorders
6.8.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Others
6.9.1 Market Size by Region, 2023-2033 (US$ Million)
6.9.2 Market Share by Region, 2023 & 2033 (%)
7 AI-based Clinical Trial Solution Providers Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
7.4 Pharmaceutical Companies
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Academia
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Others
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
8 AI-based Clinical Trial Solution Providers Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America AI-based Clinical Trial Solution Providers Market Analysis
9.1 Key Findings
9.2 North America AI-based Clinical Trial Solution Providers Market Attractiveness Index
9.3 North America AI-based Clinical Trial Solution Providers Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Country
9.5 North America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
9.6 North America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
9.7 North America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
9.8 North America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
9.9 U.S. AI-based Clinical Trial Solution Providers Market Analysis
9.10 Canada AI-based Clinical Trial Solution Providers Market Analysis
10 Europe AI-based Clinical Trial Solution Providers Market Analysis
10.1 Key Findings
10.2 Europe AI-based Clinical Trial Solution Providers Market Attractiveness Index
10.3 Europe AI-based Clinical Trial Solution Providers Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Country
10.5 Europe AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
10.6 Europe AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
10.7 Europe AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
10.9 Germany AI-based Clinical Trial Solution Providers Market Analysis
10.10 France AI-based Clinical Trial Solution Providers Market Analysis
10.11 U.K. AI-based Clinical Trial Solution Providers Market Analysis
10.12 Italy AI-based Clinical Trial Solution Providers Market Analysis
10.13 Spain AI-based Clinical Trial Solution Providers Market Analysis
10.14 Rest of Europe AI-based Clinical Trial Solution Providers Market Analysis
11 Asia Pacific AI-based Clinical Trial Solution Providers Market Analysis
11.1 Key Findings
11.2 Asia Pacific AI-based Clinical Trial Solution Providers Market Attractiveness Index
11.3 Asia Pacific AI-based Clinical Trial Solution Providers Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Country
11.5 Asia-Pacific AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
11.6 Asia-Pacific AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
11.7 Asia-Pacific AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia-Pacific AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
11.9 China AI-based Clinical Trial Solution Providers Market Analysis
11.10 Japan AI-based Clinical Trial Solution Providers Market Analysis
11.11 India AI-based Clinical Trial Solution Providers Market Analysis
11.12 Australia AI-based Clinical Trial Solution Providers Market Analysis
11.13 South Korea AI-based Clinical Trial Solution Providers Market Analysis
11.14 Rest of Asia Pacific AI-based Clinical Trial Solution Providers Market Analysis
12 Latin America AI-based Clinical Trial Solution Providers Market Analysis
12.1 Key Findings
12.2 Latin America AI-based Clinical Trial Solution Providers Market Attractiveness Index
12.3 Latin America AI-based Clinical Trial Solution Providers Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Country
12.5 Latin America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
12.6 Latin America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
12.7 Latin America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
12.9 Brazil AI-based Clinical Trial Solution Providers Market Analysis
12.10 Mexico AI-based Clinical Trial Solution Providers Market Analysis
12.11 Rest of Latin America AI-based Clinical Trial Solution Providers Market Analysis
13 MEA AI-based Clinical Trial Solution Providers Market Analysis
13.1 Key Findings
13.2 MEA AI-based Clinical Trial Solution Providers Market Attractiveness Index
13.3 MEA AI-based Clinical Trial Solution Providers Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Country
13.5 MEA AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Mode of Delivery
13.6 MEA AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Clinical Trial Phase
13.7 MEA AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA AI-based Clinical Trial Solution Providers Market Size Estimation and Forecast by End-users
13.9 GCC AI-based Clinical Trial Solution Providers Market Analysis
13.10 South Africa AI-based Clinical Trial Solution Providers Market Analysis
13.11 Rest of MEA AI-based Clinical Trial Solution Providers Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 Medidata (Dassault Systemes)
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Revenue, 2018-2022
14.3.3.2 Regional Market Shares, 2022
14.3.3.3 R&D Expense, 2018-2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Merative
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Strategic Outlook
14.5 Saama Technologies, LLC
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Strategic Outlook
14.6 Exscientia
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Revenue, 2021-2022
14.6.3.2 Regional Market Shares, 2022
14.6.3.3 R&D Expense, 2021-2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Innoplexus
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Strategic Outlook
14.8 Median Technologies
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Revenue, 2018-2022
14.8.3.2 Regional Market Shares, 2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Deep6.ai
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Strategic Outlook
14.10 AiCure
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 BioAge Labs, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Strategic Outlook
14.12 Intelligencia.ai
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 AI-based Clinical Trial Solution Providers Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Total Clinical Trials by Phase of Development
Table 3 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 4 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 5 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 7 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cloud-based Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 On-premises Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Hybrid Solutions Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Phase 3 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Phase 2 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Phase 1 Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Oncological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 CNS Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Infectious Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million,
Table 19 AGR%, CAGR%)
Table 20 Cardiovascular Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Metabolic Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million,
Table 22 AGR%, CAGR%)
Table 23 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Academia Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 U.S. AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Canada AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 36 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country,
Table 37 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 France AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 U.K. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Italy AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Spain AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Rest of Europe AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 China AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Japan AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 India AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Australia AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 South Korea AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Brazil AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Mexico AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 Medidata (Dassault Systemes): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Medidata (Dassault Systemes): Service Benchmarking
Table 78 Medidata (Dassault Systemes): Strategic Outlook
Table 79 Merative: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Merative: Service Benchmarking
Table 81 Merative: Strategic Outlook
Table 82 Saama Technologies, LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Saama Technologies, LLC: Service Benchmarking
Table 84 Saama Technologies, LLC: Strategic Outlook
Table 85 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Exscientia: Service Benchmarking
Table 87 Innoplexus: Strategic Outlook
Table 88 Innoplexus: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Innoplexus.: Service Benchmarking
Table 90 Innoplexus: Strategic Outlook
Table 91 Median Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Median Technologies: Done Benchmarking
Table 93 Innoplexus: Strategic Outlook
Table 94 Deep6.ai: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Deep6.ai: Service Benchmarking
Table 96 Deep6.ai: Strategic Outlook
Table 97 AiCure: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 AiCure: Service Benchmarking
Table 99 AiCure: Strategic Outlook
Table 100 BioAge Labs, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 BioAge Labs, Inc.: Service Benchmarking
Table 102 BioAge Labs, Inc.: Strategic Outlook
Table 103 Intelligencia.ai: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Intelligencia.ai: Service Benchmarking
List of Figures
Figure 1 AI-based Clinical Trial Solution Providers Market Segmentation
Figure 2 AI-based Clinical Trial Solution Providers Market by Mode of Delivery: Market Attractiveness Index
Figure 3 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase: Market Attractiveness Index
Figure 4 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 5 AI-based Clinical Trial Solution Providers Market Forecast by End-users: Market Attractiveness Index
Figure 6 AI-based Clinical Trial Solution Providers Market Attractiveness Index by Region
Figure 7 AI-based Clinical Trial Solution Providers Market: Market Dynamics
Figure 8 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 AI-based Clinical Trial Solution Providers Market: Porter’s Five Forces Analysis
Figure 13 AI-based Clinical Trial Solution Providers Market: PEST Analysis
Figure 14 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery: Market Attractiveness Index
Figure 15 AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 16 AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023, 2028, 2033 (%)
Figure 17 Cloud-based Market Forecast by Region, 2023 2033 (US$ Million)
Figure 18 Cloud-based Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 On-premises Market Forecast by Region, 2023-2033 (US$ Million)
Figure 20 On-premises Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Hybrid Solutions Market Forecast by Region, 2023-2033 (US$ Million)
Figure 22 Hybrid Solutions Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase: Market Attractiveness Index
Figure 24 AI-based Clinical Trial Solution Providers Market Forecast By Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 25 AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023, 2028, 2033 (%)
Figure 26 Phase 3 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Phase 3 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase 2 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Phase 2 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase 1 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 33 AI-based Clinical Trial Solution Providers Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
Figure 34 AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 35 Oncological Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 36 Oncological Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 CNS Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 38 CNS Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Infectious Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 40 Infectious Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Cardiovascular Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 42 Cardiovascular Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Metabolic Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 44 Metabolic Disorders Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 46 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 AI-based Clinical Trial Solution Providers Market Forecast by End-users: Market Attractiveness Index
Figure 48 AI-based Clinical Trial Solution Providers Market Forecast By End-users, 2023-2033 (US$ Million)
Figure 49 AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 50 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 51 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Academia Market Forecast by Region, 2023-2033 (US$ Million)
Figure 53 Academia Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 55 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 AI-based Clinical Trial Solution Providers Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 57 AI-based Clinical Trial Solution Providers Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 58 AI-based Clinical Trial Solution Providers Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 59 North America AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 60 North America AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 61 North America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 62 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 64 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 65 North America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ million)
Figure 66 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 67 North America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 68 North America AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 69 North America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 70 North America AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 71 U.S. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Canada AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 74 Europe AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 75 Europe AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 76 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 78 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 79 Europe AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 80 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 81 Europe AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 82 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 83 Europe AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 84 Europe AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Germany AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 France AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 U.K. AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Italy AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Spain AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Rest of Europe AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Asia Pacific AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 92 Asia Pacific AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 93 Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 94 Asia Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 96 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 97 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 98 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 99 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 100 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 101 Asia-Pacific AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 102 Asia-Pacific AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 103 China AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Japan AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 105 India AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Australia AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 South Korea AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Latin America AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 110 Latin America AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 112 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 114 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 115 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 116 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 117 Latin America AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 118 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 119 Latin America AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 120 Latin America AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 121 Brazil AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 Mexico AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 123 Rest of Latin America AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 MEA AI-based Clinical Trial Solution Providers Market Attractiveness Index
Figure 125 MEA AI-based Clinical Trial Solution Providers Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 126 MEA AI-based Clinical Trial Solution Providers Market Forecast by Country, 2023-2033 (US$ Million)
Figure 127 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Country, 2023 & 2033 (%)
Figure 128 MEA AI-based Clinical Trial Solution Providers Market Forecast by Mode of Delivery, 2023-2033 (US$ Million)
Figure 129 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Mode of Delivery, 2023 & 2033 (%)
Figure 130 MEA AI-based Clinical Trial Solution Providers Market Forecast by Clinical Trial Phase, 2023-2033 (US$ Million)
Figure 131 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Clinical Trial Phase, 2023 & 2033 (%)
Figure 132 MEA AI-based Clinical Trial Solution Providers Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 133 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 134 MEA AI-based Clinical Trial Solution Providers Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 135 MEA AI-based Clinical Trial Solution Providers Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 136 GCC AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 137 South Africa AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 138 Rest of MEA AI-based Clinical Trial Solution Providers Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 AI-based Clinical Trial Solution Providers Market: Company Share Analysis, 2022
Figure 140 Medidata (Dassault Systemes): Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 141 Medidata (Dassault Systemes): Regional Market Shares, 2022
Figure 142 Dassault Systèmes: R&D Expense, 2018-2022 (US$ million, AGR%)
Figure 143 Exscientia: Revenue, 2021-2022 (US$ Million, AGR%)
Figure 144 Exscientia: Regional Market Shares, 2022
Figure 145 Exscientia: R&D Expense, 2021-2022 (US$ million, AGR%)
Figure 146 Median Technologies: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 147 Median Technologies: Regional Market Shares, 2022
ページTOPに戻る
本レポートと同じKEY WORD（cardiovascular）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
